Sermorelin Dosage: What the Evidence Says (2026)
No marketed product
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
Also called: GRF 1-29, Geref
Regulatory status (US)
There is no FDA-approved sermorelin on the market. The brand Geref was approved in 1997, discontinued in 2008 and withdrawn in 2009; in 2013 the FDA determined it was not withdrawn for safety or effectiveness reasons. Compounded sermorelin does not inherit that old approval.
What it is
A fragment of growth-hormone-releasing hormone that makes the pituitary release growth hormone.
Dosage
Sermorelin reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe.
What human studies show
- Geref was approved for children with growth hormone deficiency. There is no FDA-reviewed adult dose for any use.
Safety
- No current FDA label, so there are no current approved warnings or doses.
Questions
- Is Sermorelin FDA-approved?
- There is no FDA-approved sermorelin on the market. The brand Geref was approved in 1997, discontinued in 2008 and withdrawn in 2009; in 2013 the FDA determined it was not withdrawn for safety or effectiveness reasons. Compounded sermorelin does not inherit that old approval.
- What dose of Sermorelin has been studied?
- There is no established human dose. Geref was approved for children with growth hormone deficiency. There is no FDA-reviewed adult dose for any use.
- How many units is my Sermorelin dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
15-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
GHK-Cu (copper peptide)Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
KLOW and GLOW blendsSeller-defined mixes of GHK-Cu, BPC-157, TB-500 (GLOW) plus KPV (KLOW). No human data for any blend.
Sources
- Federal Register 2013: Determination that Geref (sermorelin) was not withdrawn for safety or effectiveness
- FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.